“Ozempic face” wasn’t going to be the only possible effect of rapid weight loss from taking semaglutide, the diabetes medication marketed as Ozempic by Novo Nordisk.
A widely-shared web site posting twisted the findings of a study that looked at the impact of treating ventilator-associated pneumonia (VAP) on mortality.
6·3% of those who had taken metformin while infected with the SARS-CoV-2 ended up getting diagnosed with long Covid versus 10.4% of those who had received placebo only.